Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 48 of 48 entries
View as:

Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01855724 Org: User:
Start: 06/28/13 End: 09/28/18 Due: 09/28/19

Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01215539 Org: User:
Start: 09/30/10 End: 12/31/14 Due: 12/31/15

Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00783471 Org: User:
Start: 11/30/08 End: 06/30/10 Due: 06/30/11

Molecular Profiling in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04983628 Org: User:
Start: 10/01/20 End: 08/01/23 Due: 08/01/24

Pathogenic Variants in Homologous Recombination Repair Genes in Patients With Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04716374 Org: User:
Start: 01/31/04 End: 12/31/19 Due: 12/31/20

Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)

Phase: N/A Priority: Normal
NCT ID: NCT00790894 Org: User:
Start: 11/30/08 End: 05/31/11 Due: 05/31/12

Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06876402 Org: User:
Start: 09/09/13 End: 05/15/25 Due: 05/15/26

Preoperative Administration of Olaparib With Cisplatin or With Durvalumab or Alone or no Tratment in Patients Who Are Candidates for Surgery of Carcinoma of the Head and Neck.

Phase: N/A Priority: Normal
NCT ID: NCT02882308 Org: User:
Start: 10/20/16 End: 01/10/20 Due: 01/10/21

Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease

Phase: N/A Priority: Normal
NCT ID: NCT04805099 Org: User:
Start: 11/01/20 End: 02/28/21 Due: 02/28/22

Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04752865 Org: User:
Start: 02/09/18 End: 06/30/24 Due: 06/30/25

Molecular Profiling of Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04863768 Org: User:
Start: 01/01/06 End: 09/30/22 Due: 09/30/23

Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02129257 Org: User:
Start: 05/26/14 End: 09/25/17 Due: 09/25/18

Clinical Outcome and Toxicity Data in Patients With Advanced Breast Cancer Treated With CDK Inhibitors Combined With Endocrine Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04133207 Org: User:
Start: 01/01/19 End: 01/02/21 Due: 01/02/22

Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03311750 Org: User:
Start: 03/26/18 End: 05/20/21 Due: 05/20/22

Investigation of Gene Mutations in Patients With Triple-negative and Patients With HER2+ Breast Cancer Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04365790 Org: User:
Start: 04/18/13 End: 09/30/23 Due: 09/30/24

Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04257864 Org: User:
Start: 11/30/08 End: 06/30/14 Due: 06/30/15

K-RAS and EGFR in Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03951233 Org: User:
Start: 03/31/00 End: 12/31/14 Due: 12/31/15

RAmucirumab Combined wIth Standard Nab-paclitaxel and Gemcitabine as First-line Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03745430 Org: User:
Start: 01/29/19 End: 04/23/23 Due: 04/23/24

The Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients With Advanced EGFR Mutation-positive Non-small Cell Lung Cancer Treated With Afatinib

Phase: N/A Priority: Normal
NCT ID: NCT04640870 Org: User:
Start: 03/15/15 End: 05/31/20 Due: 05/31/21

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06666582 Org: User:
Start: 03/01/15 End: 01/15/24 Due: 01/15/25

Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05127382 Org: User:
Start: 02/01/20 End: 01/31/25 Due: 01/31/26

HNSCC Immuno-genomics Project

Phase: N/A Priority: Normal
NCT ID: NCT06725342 Org: User:
Start: 12/19/14 End: 03/01/24 Due: 03/01/25

Germline Mutations in Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03982446 Org: User:
Start: 03/01/16 End: 01/03/20 Due: 01/03/21